Lewis J. Shuster

Lewis J. Shuster

Nessuna posizione attualmente
70 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Lewis J.
Shuster
was the founder and had founded Shuster Capital in 2002, where he held the title of Chief Executive Officer until 2018.
He was also the Executive Vice President-Finance & Operations at Human Genome Sciences, Inc. from 1992 to 1994, and the President-Genomics at Invitrogen Corp.
from 2000 to 2001.
He has also served as a Director at HNI HoldCo, Inc., Response Biomedical Corp., Epitomics, Inc., Molecular Insight Pharmaceuticals, Inc., Complete Genomics, Inc., Quikbyte Software, Inc., Principia Biopharma, Inc., Turning Point Therapeutics, Inc., Active Motif, Inc., Sorrento Therapeutics, Inc., Retrotope, Inc., Cleave Therapeutics, Inc., and Tissuenetix, Inc. Shuster's education includes an MBA from Stanford University and an undergraduate degree from Swarthmore College.

Precedenti posizioni note di Lewis J. Shuster

SocietàPosizioneFine
Direttore/Membro del Consiglio 14/12/2018
Shuster Capital
Amministratore Delegato 14/12/2018
TURG POIN Direttore/Membro del Consiglio 14/12/2018
PRINCIPIA BIOPHARMA INC. Direttore/Membro del Consiglio 14/12/2018
Direttore/Membro del Consiglio 14/12/2018
Vedi nel dettaglio l'esperienza di Lewis J. Shuster

Formazione di Lewis J. Shuster

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

63

Relazioni di 1° grado

23

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private23

Health Technology

Electronic Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Services

Health Technology

Finance

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Commercial Services

Health Technology

Health Technology

Shuster Capital

Health Technology

Commercial Services

  1. Mercati
  2. Insiders
  3. Lewis J. Shuster
- 40%: I migliori strumenti riservati agli abbonati per individuare le opportunità di investimento di domani.
g
:
:
ENTRA ORA